Related Experiment Video
Updated: Sep 3, 2025

Cell Death Associated with Abnormal Mitosis Observed by Confocal Imaging in Live Cancer Cells
Published on: August 21, 2013
NUPR1 protects against hyperPARylation-dependent cell death.
Patricia Santofimia-Castaño1, Can Huang1, Xi Liu1
1Centre de Recherche en Cancérologie de Marseille (CRCM), Parc Scientifique et Technologique de Luminy, INSERM U1068, CNRS UMR 7258, Institut Paoli-Calmettes, Aix-Marseille Université, Marseille, France.
The stress protein NUPR1 inhibits PARP1 activity. Its inactivation causes mitochondrial damage and cell death via a non-canonical Parthanatos pathway, offering new therapeutic targets for cancer.
Area of Science:
- Cellular Biology
- Molecular Biology
- Biochemistry
Background:
- The stress-associated protein NUPR1 plays a role in cellular responses.
- Poly(ADP-ribose) polymerase 1 (PARP1) is a key enzyme in DNA repair and cell death pathways.
Purpose of the Study:
- To investigate the interaction between NUPR1 and PARP1.
- To elucidate the role of NUPR1 in regulating PARP1 activity and its downstream effects on cell death.
- To explore potential therapeutic strategies targeting this pathway in cancer.
Main Methods:
- Proteomic, cellular, and biochemical analyses.
- In vitro assays to study protein-protein interactions and enzyme activity.
- Treatment with NUPR1 inhibitor (ZZW-115), PARP inhibitor (olaparib), PARG inhibitor (PDD00017273), and NAD+ precursor.
- Analysis of mitochondrial function, ROS production, and calcium levels.
Main Results:
- NUPR1 binds to PARP1 in the nucleus and inhibits its activity.
- NUPR1 inactivation or inhibition enhances 5-fluorouracil-induced PARylation and cell death.
- ZZW-115 treatment induces mitochondrial catastrophe, characterized by hyperPARylation, mitochondrial dysfunction, and increased ROS/Ca2+.
- Olaparib and nicotinamide mononucleotide rescue these effects, suggesting a role for NAD+ depletion and PARP hyperactivation.
Conclusions:
- NUPR1 inactivation triggers a non-canonical Parthanatos pathway, leading to mitochondrial catastrophe and cell death.
- Targeting the NUPR1-PARP1 interaction or downstream pathways presents a potential therapeutic strategy for pancreatic cancer.
More Related Videos
Related Concept Videos
Abnormal Proliferation
DNA Damage can Stall the Cell Cycle
Negative Regulator Molecules
The Intrinsic Apoptotic Pathway
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
Nucleotide Excision Repair
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...

